Hepatic injury and drug metabolism in patients with alpha-methyldopa-induced liver damage.
D000328:Adult; D000368:Aged; D000983:Antipyrine / Q000378:metabolism; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology* / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D005260:Female; D006207:Half-Life; D006801:Humans; D008099:Liver / Q000473:pathology; D008297:Male; D008750:Methyldopa / Q000009:adverse effects*; D008875:Middle Aged; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D013997:Time Factors
D004364:Pharmaceutical Preparations; D008750:Methyldopa; D003577:Cytochrome P-450 Enzyme System; D000983:Antipyrine